Aberdeen Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $128M | Sell |
|
|||||
|
2025
Q1 | $147M | Sell |
|
|||||
|
2024
Q4 | $139M | Sell |
|
|||||
|
2024
Q3 | $173M | Sell |
|
|||||
|
2024
Q2 | $174M | Sell |
|
|||||
|
2024
Q1 | $240M | Sell |
|
|||||
|
2023
Q4 | $236M | Buy |
|
|||||
|
2023
Q3 | $68.3M | Sell |
|
|||||
|
2023
Q2 | $69.4M | Sell |
|
|||||
|
2023
Q1 | $62.7M | Buy |
|
|||||
|
2022
Q4 | $53.1M | Sell |
|
|||||
|
2022
Q3 | $54.1M | Buy |
|
|||||
|
2022
Q2 | $29.8M | Buy |
|
|||||
|
2022
Q1 | $25.1M | Buy |
|
|||||
|
2021
Q4 | $20.8M | Sell |
|
|||||
|
2021
Q3 | $94.3M | Sell |
|
|||||
|
2021
Q2 | $106M | Buy |
|
|||||
|
2021
Q1 | $20.9M | Buy |
|
|||||
|
2020
Q4 | $21.3M | Buy |
|
|||||
|
2020
Q3 | $23.7M | Sell |
|
|||||
|
2020
Q2 | $28.9M | Sell |
|
|||||
|
2020
Q1 | $24.1M | Sell |
|
|||||
|
2019
Q4 | $27.5M | Sell |
|
|||||
|
2019
Q3 | $21.6M | Sell |
|
|||||
|
2019
Q2 | $33.3M | Sell |
|
|||||
|
2019
Q1 | $53.4M | Sell |
|
|||||
|
2018
Q4 | $117M | Sell |
|
|||||
|
2018
Q3 | $171M | Sell |
|
|||||
|
2018
Q2 | $195M | Buy |
|
|||||
|
2018
Q1 | $55.1M | Buy |
|
|||||
|
2017
Q4 | $25.1M | Buy |
|
|||||
|
2017
Q3 | $10.9M | Buy |
|